Australian Biotech Stock News

ASX:LNW
ASX:LNWHospitality

Why Light & Wonder (ASX:LNW) Is Up 16.0% After Major IP Settlement With Aristocrat Leisure – And What's Next

In early January 2026, Aristocrat Leisure and Light & Wonder settled intellectual property litigation in Australia and the United States, with Light & Wonder agreeing to pay Aristocrat US$127.5 million, halt global commercialization of Dragon Train and Jewel of the Dragon, and destroy related materials. The settlement underlines how crucial proprietary game mathematics and intellectual property protection have become for competition and product development in the global gaming...
ASX:PPS
ASX:PPSSoftware

ASX Penny Stocks To Watch In January 2026

The Australian market is showing resilience, with shares set to advance by 0.33% following positive trends in global markets despite political uncertainties surrounding the Federal Reserve. In such a climate, investors often look towards smaller or newer companies for potential growth opportunities. Penny stocks, while sometimes considered outdated, can still offer significant value when backed by strong financials and stability. This article will explore three penny stocks that stand out for...
ASX:DOW
ASX:DOWCommercial Services

A Look At Downer EDI’s Valuation As Allan Gray Exits As A Substantial Shareholder

Why Allan Gray’s exit matters for Downer EDI Allan Gray Australia and its related entities stepping back from substantial shareholder status in Downer EDI (ASX:DOW) puts the company’s ownership structure in focus for anyone tracking the stock’s recent performance. See our latest analysis for Downer EDI. At a share price of A$7.97, Downer EDI has a 90 day share price return of 5.98%, while its 1 year total shareholder return of 61.87% suggests momentum has been building over a longer stretch...